{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T21:16:41Z","timestamp":1766611001523,"version":"3.48.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,24]]},"DOI":"10.7759\/cureus.100024","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T21:11:48Z","timestamp":1766610708000},"source":"Crossref","is-referenced-by-count":0,"title":["Melatonin Attenuates Androgen-Induced Visceral Adiposity in an Experimental Polycystic Ovary Syndrome Model"],"prefix":"10.7759","author":[{"given":"Nina","family":"Tirso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emina","family":"Kiseljakovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almir","family":"Fajki\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samra","family":"Custovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maida","family":"Sahinovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"Lepara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"120","author":"Teede HJ","year":"2023","unstructured":"Teede HJ, Tay CT, Laven J, et al.. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2023, 120:767-93. 10.1016\/j.fertnstert.2023.07.025","journal-title":"Fertil Steril"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041500","article-title":"Polycystic ovary syndrome: Challenges and possible solutions","volume":"12","author":"Che Y","year":"2023","unstructured":"Che Y, Yu J, Li YS, Zhu YC, Tao T. Polycystic ovary syndrome: Challenges and possible solutions. J Clin Med. 2023, 12:1500. 10.3390\/jcm12041500","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01516-x","article-title":"Adolescent polycystic ovary syndrome according to the international evidence-based guideline","volume":"18","author":"Pe\u00f1a AS","year":"2020","unstructured":"Pe\u00f1a AS, Witchel SF, Hoeger KM, et al.. Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med. 2020, 18:72. 10.1186\/s12916-020-01516-x","journal-title":"BMC Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/719050","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: Navigating the pathophysiologic labyrinth","volume":"2014","author":"Rojas J","year":"2014","unstructured":"Rojas J, Ch\u00e1vez M, Olivar L, et al.. Polycystic ovary syndrome, insulin resistance, and obesity: Navigating the pathophysiologic labyrinth. Int J Reprod Med. 2014, 2014:719050. 10.1155\/2014\/719050","journal-title":"Int J Reprod Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz R","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004, 89:2745-9. 10.1210\/jc.2003-032046","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1117761","article-title":"High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome","volume":"14","author":"Butler AE","year":"2023","unstructured":"Butler AE, Moin AS, Reiner \u017d, Sathyapalan T, Jamialahmadi T, Sahebkar A, Atkin SL. High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023, 14:1117761. 10.3389\/fendo.2023.1117761","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1514916","article-title":"Polycystic ovary syndrome","volume":"375","author":"McCartney CR","year":"2016","unstructured":"McCartney CR, Marshall JC. Polycystic ovary syndrome. N Engl J Med. 2016, 375:54-64. 10.1056\/NEJMcp1514916","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.782808","article-title":"Correlation between serum uric acid and body fat distribution in patients with polycystic ovary syndrome","volume":"12","author":"Zhang Y","year":"2021","unstructured":"Zhang Y, Cai M, Dilimulati D, et al.. Correlation between serum uric acid and body fat distribution in patients with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021, 12:782808. 10.3389\/fendo.2021.782808","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/38447238","article-title":"The clinical importance of visceral adiposity: A critical review of methods for visceral adipose tissue analysis","volume":"85","author":"Shuster A","year":"2012","unstructured":"Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: A critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012, 85:1-10. 10.1259\/bjr\/38447238","journal-title":"Br J Radiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61030424","article-title":"Visceral and dysfunctional adiposity indices as predictors of insulin resistance and metabolic syndrome in women with polycystic ovary syndrome: A cross-sectional study","volume":"61","author":"Keyif B","year":"2025","unstructured":"Keyif B, Yavuzcan A. Visceral and dysfunctional adiposity indices as predictors of insulin resistance and metabolic syndrome in women with polycystic ovary syndrome: A cross-sectional study. Medicina (Kaunas). 2025, 61:424. 10.3390\/medicina61030424","journal-title":"Medicina (Kaunas)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s43043-023-00158-2","article-title":"Inflammatory perspectives of polycystic ovary syndrome: Role of specific mediators and markers","author":"Dey R","year":"202328","unstructured":"Dey R, Bhattacharya K, Basak AK, et al.. Inflammatory perspectives of polycystic ovary syndrome: Role of specific mediators and markers. Middle East Fertil Soc J. 202328, 33. 10.1186\/s43043-023-00158-2","journal-title":"Middle East Fertil Soc J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.731569","article-title":"The association between genetically predicted systemic inflammatory regulators and polycystic ovary syndrome: A Mendelian randomization study","volume":"12","author":"Chen H","year":"2021","unstructured":"Chen H, Zhang Y, Li S, et al.. The association between genetically predicted systemic inflammatory regulators and polycystic ovary syndrome: A Mendelian randomization study. Front Endocrinol (Lausanne). 2021, 12:731569. 10.3389\/fendo.2021.731569","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.18502\/jri.v24i1.11906","article-title":"The association between increment of interleukin-1 and interleukin-6 in women with polycystic ovary syndrome and body mass index","volume":"24","author":"Mazloomi S","year":"2023","unstructured":"Mazloomi S, Barartabar Z, Pilehvari S. The association between increment of interleukin-1 and interleukin-6 in women with polycystic ovary syndrome and body mass index. J Reprod Infertil. 2023, 24:26-34. 10.18502\/jri.v24i1.11906","journal-title":"J Reprod Infertil"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-025-01621-6","article-title":"Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation","volume":"18","author":"Su P","year":"2025","unstructured":"Su P, Chen C, Sun Y. Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation. J Ovarian Res. 2025, 18:34. 10.1186\/s13048-025-01621-6","journal-title":"J Ovarian Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041667","article-title":"Oxidative stress and low-grade inflammation in polycystic ovary syndrome: controversies and new insights","volume":"22","author":"Mancini A","year":"2021","unstructured":"Mancini A, Bruno C, Vergani E, d'Abate C, Giacchi E, Silvestrini A. Oxidative stress and low-grade inflammation in polycystic ovary syndrome: controversies and new insights. Int J Mol Sci. 2021, 22:1667. 10.3390\/ijms22041667","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.675355","article-title":"Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study","volume":"116","author":"Fox CS","year":"2007","unstructured":"Fox CS, Massaro JM, Hoffmann U, et al.. Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007, 116:39-48. 10.1161\/CIRCULATIONAHA.106.675355","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2017.12.001","article-title":"Correlation of visceral body fat with waist-hip ratio, waist circumference and body mass index in healthy adults: A cross sectional study","volume":"76","author":"Gadekar T","year":"2020","unstructured":"Gadekar T, Dudeja P, Basu I, Vashisht S, Mukherji S. Correlation of visceral body fat with waist-hip ratio, waist circumference and body mass index in healthy adults: A cross sectional study. Med J Armed Forces India. 2020, 76:41-6. 10.1016\/j.mjafi.2017.12.001","journal-title":"Med J Armed Forces India"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q514","article-title":"Polycystic ovary syndrome and chronic inflammation: Pharmacotherapeutic implications","volume":"46","author":"Sirmans SM","year":"2012","unstructured":"Sirmans SM, Weidman-Evans E, Everton V, Thompson D. Polycystic ovary syndrome and chronic inflammation: Pharmacotherapeutic implications. Ann Pharmacother. 2012, 46:403-18. 10.1345\/aph.1Q514","journal-title":"Ann Pharmacother"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.126295","article-title":"Melatonin and its correlation with testosterone in polycystic ovarian syndrome","volume":"6","author":"Jain P","year":"2013","unstructured":"Jain P, Jain M, Haldar C, Singh TB, Jain S. Melatonin and its correlation with testosterone in polycystic ovarian syndrome. J Hum Reprod Sci. 2013, 6:253-8. 10.4103\/0974-1208.126295","journal-title":"J Hum Reprod Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.05.016","article-title":"Melatonin and the ovary: Physiological and pathophysiological implications","volume":"92","author":"Tamura H","year":"2009","unstructured":"Tamura H, Nakamura Y, Korkmaz A, Manchester LC, Tan DX, Sugino N, Reiter RJ. Melatonin and the ovary: Physiological and pathophysiological implications. Fertil Steril. 2009, 92:328-43. 10.1016\/j.fertnstert.2008.05.016","journal-title":"Fertil Steril"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.18502\/ijrm.v17i12.5789","article-title":"The role of melatonin in polycystic ovary syndrome: A review","volume":"17","author":"Mojaverrostami S","year":"2019","unstructured":"Mojaverrostami S, Asghari N, Khamisabadi M, Heidari Khoei H. The role of melatonin in polycystic ovary syndrome: A review. Int J Reprod Biomed. 2019, 17:865-82. 10.18502\/ijrm.v17i12.5789","journal-title":"Int J Reprod Biomed"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.06.013","article-title":"Persistent estrus rat models of polycystic ovary disease: An update","volume":"84","author":"Singh KB","year":"2005","unstructured":"Singh KB. Persistent estrus rat models of polycystic ovary disease: An update. Fertil Steril. 2005, 84:1228-34. 10.1016\/j.fertnstert.2005.06.013","journal-title":"Fertil Steril"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2011.26.3.193","article-title":"Animal models for the study of polycystic ovarian syndrome","volume":"26","author":"Oackley O","year":"2011","unstructured":"Oackley O, Lin PC, Bridges P, Ko CM. Animal models for the study of polycystic ovarian syndrome. Endocrinol Metab. 2011, 26:193-202. 10.3803\/EnM.2011.26.3.193","journal-title":"Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12297","article-title":"Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats","volume":"66","author":"Pai SA","year":"2014","unstructured":"Pai SA, Majumdar AS. Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats. J Pharm Pharmacol. 2014, 66:1710-21. 10.1111\/jphp.12297","journal-title":"J Pharm Pharmacol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa010","article-title":"Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome","volume":"41","author":"Stener-Victorin E","year":"2020","unstructured":"Stener-Victorin E, Padmanabhan V, Walters KA, et al.. Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocr Rev. 2020, 41:10.1210\/endrev\/bnaa010","journal-title":"Endocr Rev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1211231","article-title":"The interplay of oxidative stress and immune dysfunction in Hashimoto's thyroiditis and polycystic ovary syndrome: A comprehensive review","volume":"14","author":"Bat\u00f3g G","year":"2023","unstructured":"Bat\u00f3g G, Do\u0142oto A, B\u0105k E, Pi\u0105tkowska-Chmiel I, Krawiec P, Pac-Ko\u017cuchowska E, Herbet M. The interplay of oxidative stress and immune dysfunction in Hashimoto's thyroiditis and polycystic ovary syndrome: A comprehensive review. Front Immunol. 2023, 14:1211231. 10.3389\/fimmu.2023.1211231","journal-title":"Front Immunol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3923\/pjbs.2018.340.347","article-title":"Therapeutic efficacy of melatonin against polycystic ovary syndrome (PCOS) induced by letrozole in Wistar rat","volume":"21","author":"Basheer M","year":"2018","unstructured":"Basheer M, Rai S, Ghosh H, Ahmad Hajam Y. Therapeutic efficacy of melatonin against polycystic ovary syndrome (PCOS) induced by letrozole in Wistar rat. Pak J Biol Sci. 2018, 21:340-7. 10.3923\/pjbs.2018.340.347","journal-title":"Pak J Biol Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12262","article-title":"Animal models of polycystic ovary syndrome: A review of hormone-induced rodent models focused on hypothalamus-pituitary-ovary axis and neuropeptides","volume":"18","author":"Osuka S","year":"2019","unstructured":"Osuka S, Nakanishi N, Murase T, Nakamura T, Goto M, Iwase A, Kikkawa F. Animal models of polycystic ovary syndrome: A review of hormone-induced rodent models focused on hypothalamus-pituitary-ovary axis and neuropeptides. Reprod Med Biol. 2019, 18:151-60. 10.1002\/rmb2.12262","journal-title":"Reprod Med Biol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.65.7.1008","article-title":"Melatonin may prevent or reverse polycystic ovary syndrome in rats","volume":"65","author":"Lombardi LA","year":"2019","unstructured":"Lombardi LA, Mattos LS, Sim\u00f5es RS, et al.. Melatonin may prevent or reverse polycystic ovary syndrome in rats. Rev Assoc Med Bras (1992). 2019, 65:1008-14. 10.1590\/1806-9282.65.7.1008","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00273","article-title":"Effects of melatonin supplementation on hormonal, inflammatory, genetic, and oxidative stress parameters in women with polycystic ovary syndrome","volume":"10","author":"Jamilian M","year":"2019","unstructured":"Jamilian M, Foroozanfard F, Mirhosseini N, et al.. Effects of melatonin supplementation on hormonal, inflammatory, genetic, and oxidative stress parameters in women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2019, 10:273. 10.3389\/fendo.2019.00273","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/441801-melatonin-attenuates-androgen-induced-visceral-adiposity-in-an-experimental-polycystic-ovary-syndrome-model","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T21:11:49Z","timestamp":1766610709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/441801-melatonin-attenuates-androgen-induced-visceral-adiposity-in-an-experimental-polycystic-ovary-syndrome-model"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.100024","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,24]]}}}